Jan 15, 2020
Lytix Biopharma among 11 finalists at the third annual Lyfebulb-Helsinn Innovation Summit

We are pleased to share that we are among the 11 finalists participating in the third annual Lyfebulb-Helsinn Innovation Summit (in Monaco, January 29-30).

The Lyfebulb-Helsinn Innovation Award will be presented to an exceptional innovator with outstanding entrepreneurial potential to commercialize a creative idea to better manage cancer using drugs, medical devices or healthcare information technology.

 

See the press release here

See the website with each finalist’s headshot and bio here